|
S.S. Apetov, V.V. Apetova
The role of menopausal hormone therapy in the prevention of type 2 diabetes melltus in postmenopausal women
|
№4 / 2022
|
|
N.V. Kazachenko (1), V.V. Platonov (1–3), M.E. Turkunova (3), Yu.L. Skorodok (3), E.Yu. Smirnova (4)
Progeroid syndrome caused by a defect in the WRN gene. Description of a clinical case in a teenager
|
№12 / 2021
|
|
N.I. Volkova, S.O. Panenko, A.O. Golubeva
Is non-alcoholic fatty liver disease a consequence of obesity and a predictor of diabetes?
|
№12 / 2021
|
|
A.F. Verbovoy, Yu.A. Dolgikh
Insulin resistance – a common enemy for endocrinologists and cardiologists
|
№12 / 2021
|
|
M.V. Gorbunova (1), S.L. Babak (1), V.S. Borovitsky (2), A.G. Malyavin (1)
Effect of long-term CPAR therapy on metabolic profile of patients with mild obstructive sleep apnea
|
№5 / 2021
|
|
E.V. Biryukova, I.V. Solovyova
Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?
|
№4 / 2019
|
|
N.S. Alekseeva (1), E.V. Beloborodova (2)
The effectiveness of therapeutic measures in metabolic syndrome and vitamin d deficiency
|
№4 / 2019
|
|
A.F. Verbovoy, Yu.A. Dolgikh, O.V. Kosareva, L.A. Sharonova, I.A. Tsanava
INSULIN RESISTANCE AND THYROID HORMONES
|
№5 / 2017
|
|
L.A. Sharonova, A.F. Verbovoy, I.A. Tsanava
STATE OF CARDIOVASCULAR SYSTEM IN METABOLIC SYNDROME
|
№5 / 2017
|
|
A.F. Verbovoy, L.A. Sharonova, A.V. Pashentseva, I.A. Tsanava
INSULIN RESISTANCE SYNDROME IN THE CLINIC OF INTERNAL DISEASES
|
№5 / 2017
|
|
A.S. Ametov
PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS
|
№5 / 2017
|
|
S.N. Tolstov (1, 2), I.A. Salov (1, 2), A.P. Rebrov (1)
SEVERITY OF ABDOMINAL OBESITY AND CARBOHYDRATE METABOLISM DISORDERS IN MENOPAUSAL WOMEN AND POTENTIALS FOR THE CORRECTION OF THE REVEALED VIOLATIONS
|
№3 / 2017
|
Русский
